These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 15641241

  • 21. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A, Sumethkul V, Chalermsanyakorn P, Jirasiritham S.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [Abstract] [Full Text] [Related]

  • 22. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the efficacy and safety of Consupren solution and Sandimmun Neoral solution, 50 ml in stable heart transplant patients.
    Toman J, Spinarová L, Krejcí J, Hude P, Kopecná E, Kamarád V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2002 Dec; 146(2):87-90. PubMed ID: 12572904
    [Abstract] [Full Text] [Related]

  • 24. [Cyclosporine microemulsion C2 monitoring in Chinese adult liver transplant recipients: a preliminary randomized control trial].
    Chen G, He Y, Wang HZ, Lu Q, Yang SZ, Yang ZY, Dong JH.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 01; 43(19):1243-7. PubMed ID: 16271221
    [Abstract] [Full Text] [Related]

  • 25. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 01; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 26. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
    Transpl Int; 2006 Aug 01; 19(8):657-66. PubMed ID: 16827683
    [Abstract] [Full Text] [Related]

  • 27. Limitations of C2 monitoring in renal transplant recipients.
    Einecke G, Schütz M, Mai I, Fritsche L, Giessing M, Glander P, Neumayer HH, Budde K.
    Nephrol Dial Transplant; 2005 Jul 01; 20(7):1463-70. PubMed ID: 15840681
    [Abstract] [Full Text] [Related]

  • 28. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Higgins RM, Kanji H, Hernon M, Harrison P, Lam FT, Kashi SH.
    Transpl Int; 2005 Jul 01; 18(7):806-10. PubMed ID: 15948859
    [Abstract] [Full Text] [Related]

  • 29. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P, Ortiz AM, Jara A, Vilches S.
    Transplant Proc; 2009 Jul 01; 41(1):127-30. PubMed ID: 19249495
    [Abstract] [Full Text] [Related]

  • 30. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I, Viklický O, Voska L, Lodererová A, Vítko S.
    Transpl Int; 2005 Jun 01; 18(6):668-71. PubMed ID: 15910291
    [Abstract] [Full Text] [Related]

  • 31. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
    Ghisdal L, Bouchta NB, Broeders N, Crenier L, Hoang AD, Abramowicz D, Wissing KM.
    Transpl Int; 2008 Feb 01; 21(2):146-51. PubMed ID: 17971033
    [Abstract] [Full Text] [Related]

  • 32. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
    Kyllönen LE, Salmela KT.
    Transplantation; 2006 Apr 15; 81(7):1010-5. PubMed ID: 16612277
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporin twice or three times daily dosing in pediatric transplant patients - it is not the same!
    Filler G, de Barros VR, Jagger JE, Christians U.
    Pediatr Transplant; 2006 Dec 15; 10(8):953-6. PubMed ID: 17096765
    [Abstract] [Full Text] [Related]

  • 34. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR, Lin CC, Lian JD.
    Transplant Proc; 2007 Dec 15; 39(10):3135-41. PubMed ID: 18089339
    [Abstract] [Full Text] [Related]

  • 35. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring.
    Sharma A, Shekhar C, Heer M, Minz M.
    Transplant Proc; 2006 Sep 15; 38(7):2051-3. PubMed ID: 16979996
    [Abstract] [Full Text] [Related]

  • 36. Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study.
    Barbari AG, Masri MA, Stephan AG, El Ghoul B, Rizk S, Mourad N, Kamel GS, Kilani HE, Karam AS.
    Exp Clin Transplant; 2006 Jun 15; 4(1):400-5. PubMed ID: 16827634
    [Abstract] [Full Text] [Related]

  • 37. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S, Vareesangthip K, Ong-ajyooth L.
    J Med Assoc Thai; 2006 Aug 15; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [Abstract] [Full Text] [Related]

  • 38. Single daily dose administration of cyclosporine in renal transplant recipients.
    Halim MA, Said T, Al-Otaibi T, Eleawa S, Al-Maged H, Gawish AE, Nair P, Al-Muzairai I, Nampoory MR, Al-Mousawi M.
    Transplant Proc; 2007 May 15; 39(4):1225-7. PubMed ID: 17524939
    [Abstract] [Full Text] [Related]

  • 39. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
    Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C.
    Transplant Proc; 2005 Mar 15; 37(2):788-90. PubMed ID: 15848532
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H, Pflugfelder P, Haddad H, Cantarovich M, White M, Ignaszewski A, Howlett J, Vaillancourt M, Dorent R, Burton JR, CADENCE Study Group.
    J Heart Lung Transplant; 2008 Feb 15; 27(2):197-202. PubMed ID: 18267227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.